Gestational diabetes screening the international association of the diabetes and pregnancy study groups compared with carpenter-coustan screening

Obstetrics and Gynecology

Volumn 127, Issue 1, 2016, Pages 10-17

  Klara Feldman, R ^a   Tieu, Ryan S ^a   Yasumura, Lyn ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

ADULT; ARTICLE; BODY MASS; CESAREAN SECTION; COHORT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; HYPERBILIRUBINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MAJOR CLINICAL STUDY; NEWBORN INTENSIVE CARE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; BIRTH WEIGHT; BLOOD; BLOOD GLUCOSE MONITORING; CALIFORNIA; COMPARATIVE STUDY; DIABETES, GESTATIONAL; EPIDEMIOLOGY; FETAL MACROSOMIA; MASS SCREENING; NEWBORN; PATIENT EDUCATION; PRE-ECLAMPSIA; PREMATURE BIRTH; PROCEDURES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BIRTH WEIGHT; BLOOD GLUCOSE SELF-MONITORING; CALIFORNIA; CESAREAN SECTION; CONTROLLED BEFORE-AFTER STUDIES; DIABETES, GESTATIONAL; FEMALE; FETAL MACROSOMIA; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; MASS SCREENING; PATIENT EDUCATION AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84952718093     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001132     Document Type: Article

References (21)

1. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-Trimester glucose tolerance in the Pima Indians. Diabetes Care 1980;3:458-64.
2. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Mølsted-Pedersen L, Damm P. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose? Acta Obstet Gynecol Scand 2008; 87:59-62.
3. Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146-56.
4. Ferrara A, Weiss NS, Hedderson MM, Quesenberry CP Jr, Selby JV, Ergas IJ, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007;50:298-306.
5. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Clinical practice guideline. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
6. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: A systemic review and meta-Analysis. Lancet 2009;373:1773-9.
7. Metzger BE. Long-Term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 2007;50:972-9.
8. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290-6.
9. Gestational diabetes mellitus. Practice Bulletin No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;122:406-16.
10. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.
11. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21(suppl 2):B161-7.
12. Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. National Diabetes Data Group. Diabetes 1979;28:1039-57.
13. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-82.
14. Bonomo M, Corica D, Mion E, Goncalves D, Motta G, Merati R, et al. Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: A randomized clinical trial. Diabet Med 2005;22:1536-41.
15. Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am J Perinatol 1999;16:269-75.
16. Crowther CA, Hiller JE, Moss JR, McPhee JA, Jeffries WS, Robinson JS, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-86.
17. HAPO Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: Associations with neonatal anthropometrics. Diabetes 2009;58:453-9.
18. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358: 1991-2002.
19. Black MH, Sacks DA, Xiang AH, Lawrence JM. The Relative Contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal Overgrowth. Diabetes Care 2013;36:56-62.
20. Di Benedetto A, Danna R, Cannata ML, Giordano D, Interdonato ML, Corrado F. Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-Tolerant women. Diabetes Metab 2012;38:63-7.
21. Ferrara A. Increasing prevalence of gestational diabetes mellitus. A public health perspective. Diabetes Care 2007;30(suppl 2):S141-6.